• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number 10371
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Pericardial Effusion (3271)
Event Date 12/06/2019
Event Type  Injury  
Event Description
It was reported a pericardial effusion occurred.A left atrial appendage (laa) closure procedure was being performed.The transeptal puncture was performed.Two watchman access systems (was) and two 24mm watchman laa closure device and delivery systems (wds) were attempted to be used during the procedure.The first was and wds were used and removed from the patient.While preparing the 2nd was and 2nd wds, a pericardial effusion measuring 1.5cm was noticed.The was and wds were not in the patient when the pericardial effusion was noticed.The patient's blood pressure dropped and the procedure was aborted.The patient's activated clotting time was 246.A pericardiocentesis was performed and reversal agents were given.The total blood loss was 350ml.The patient stabilized and no blood was given.The patient was sent to the intensive care unit with a drain to be observed overnight.Echocardiogram evaluation showed the patient was stable on multiple repeat echocardiograms over the following hour.The patient was doing well and was expected to be discharged about a week post procedure.It was noted that the physician believed the pericardial effusion happened at the transeptal crossing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM
Type of Device
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key9488735
MDR Text Key171895760
Report Number2134265-2019-15928
Device Sequence Number1
Product Code NGV
UDI-Device Identifier08714729838234
UDI-Public08714729838234
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 12/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/18/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/26/2022
Device Model Number10371
Device Catalogue Number10371
Device Lot Number0024334273
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/06/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/27/2019
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-